longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Maravai LifeSciences

MRVI

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -22.43, below the reasonable range, cheaper than 98.62% of the time in the past 5 years, and the industry ranks 50/59, the industry Median -1.56.

-22.43xP/E
$6.69Stock price
$-0.30Earnings per share
-22.43xP/E
Stock price$6.69Earnings per share$-0.30

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-2.97x
Typical range
-8.92x–18.92x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
09182736

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
P/E ratio
Name/Symbol
LZAGYUSLonza
-331.46x--$45.68B
CRLUSCharles River Laboratorie
-54.68x228.46%$13.04B
TEMUSTempus AI
-43.87x1.23%$11.16B
AVTRUSAvantor
-17.74x142.83%$10.25B
TXGUS10X Genomics
-121.59x105.18%$9.13B
BRKRUSBruker
-75.05x7.71%$8.02B
ADPTUSAdaptive Biotechnologies
-61.93x39.66%$3.95B
ABCLUSAbcellera Biologics
-21.98x34.69%$3.62B
ALMRUSAlamar Biosciences
-39.11x80.55%$1.94B
PSNLUSPersonalis
-16.23x20.05%$1.74B
MRVIUSMaravai LifeSciences
-22.43x65.83%$1.74B
FTREUSFortrea
-19.43x93.77%$1.66B
AZTAUSAzenta
-11.42x179.62%$1.40B
CYRXUSCryoport
-17.81x156.25%$808.36M
OABIUSOmniAb
-14.71x35.96%$651.35M
CTKBUSCytek Biosciences
-7.79x33.98%$627.82M
EVOUSEvotec SE
-2.61x390.22%$596.75M
DNAUSGinkgo Bioworks
-1.62x35.20%$472.06M
PACBUSPacific Biosc California
-3.19x75.82%$419.62M
TKNOUSAlpha Teknova
-21.84x4.69%$366.15M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.